Tuesday, 16 Jul 2019

You are here

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.

  1. FDG-PET Scans in large vessel vasculitis (eg, Takayasus) capable to detecting active disease with 85% sensitivity and 83% specificity. Abnormal PET during remission, predicts 5 fold high risk of relapse. https://t.co/r2r2oCk0Kj
  2. Viscosupplementation of the hip joint DOES NOT WORK in numerous RTCs - with little/no evidence of efficacy at 3 and 6 months. https://t.co/rOk9JJ8uYI
  3. Curcumin combined with boswellic acid shown to be effective in 201 osteoarthritis patients in a randomized, double-blind, placebo-controlled study. https://t.co/Mlai1P7Yww
  4. Anti-mitochondrial antibodies found with inflammatory myositis may be associated with severe cardiac involvement. 4/7 had necrotizing myopathy and 3/7 had other autoimmune Dz - PBC, autoimmune hepatitis, Psoriasis, Hashimoto’s https://t.co/bssYfmQXfl
  5. A substudy within the BeST study found that TNF inhibitor Rx associated with less Xray development of OA in DIP (but not PIP) joints - 2.3% less for every month of TNFi Rx. https://t.co/zh8WD2DUcW
  6. Of 134 RTX treated pts (mean 79 mos), 23 (17%) developed Hypogammaglobulinemia after a mean 64 mos & assoc w/ 4x risk of severe infections. Gammaglobulin <8 g/L at baseline was a predictor of hypogamma (HR 7.34), but MTX was protective (HR 0.26)    https://t.co/AMOtNAUeXR
  7. Hip Replacement Augments Longevity  http://rheumnow.com/content/hip-replacement-augments-longevity 
  8. Gout Crystal Deposition is Deeper than its Measures    http://rheumnow.com/content/gout-crystal-deposition-deeper-its-measures
  9. Probenecid Benefits Heart Failure   http://rheumnow.com/content/probenecid-benefits-heart-failure
  10. IL-18 Binding Protein Effective in Adult-Onset Still's Disease  http://rheumnow.com/content/il-18-binding-protein-effective-adult-onset-...

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Boiling Hot MAS (7.12.19)

Dr. Jack Cush reviews this week's news and journal reports featured on RheumNow.com. PsA v. non-PsA pregnancies, Still's disease, lupus, nutritional supplements and dietary interventions, use of cannabis, tanezumab in OA, CBD oils and more.

Be ‘on point’: Guidelines for rheumatic complications of immunotherapy

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. At EULAR 2019, Madrid, several recommendations including RA, SLE, and Sjogren’s syndrome have been developed. Agreement for principles with respect to the treatment of immune mediated adverse events from cancer immunotherapy are lacking.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019, including low-dose steroids in hand OA, ABA vs. ADA in double positive RA patients, psoriasis predictors of PsA, tildrakizumab and more.

EULAR 2019 – Day 3 Report

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.

Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis 

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rheumatic and Musculoskeletal Medicine presented at EULAR 2019.